NeuroPace, Inc.

NASDAQ:NPCE

10.97 (USD) • At close March 12, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420232022202120202019
Operating Activities:
Net Income -27.141-32.956-47.082-36.08-24.278-29.973
Depreciation & Amortization 1.7691.6052.9870.2960.3120.421
Deferred Income Tax 0005.4780.187-0.944
Stock Based Compensation 10.2829.5588.3494.2881.3791.442
Change In Working Capital -5.453-2.484-4.7880.368-2.0670.009
Accounts Receivables -0.537-4.85-0.3911.304-2.378-0.75
Inventory 0.251-1.698-2.133-1.1560.672-1.638
Accounts Payables 0.6710.240.6470.479-0.005-0.082
Other Working Capital -5.8383.824-2.911-0.259-0.3562.479
Other Non Cash Items 2.5944.5763.6651.0732.8584.019
Operating Cash Flow -17.949-19.701-36.869-24.577-21.609-25.026
Investing Activities:
Investments In Property Plant And Equipment 0-0.173-0.603-0.384-0.062-0.468
Acquisitions Net 000010.7050.004
Purchases Of Investments 000-85.012-17.005-18.018
Sales Maturities Of Investments 9.323.224.406.322.1
Other Investing Activites -0.306024.4-85.012-10.7054.086
Investing Cash Flow 8.99423.02723.797-85.396-10.7673.618
Financing Activities:
Debt Repayment 000-4.0924.46221.328
Common Stock Issued 3.2777.8880.896109.08931.4970.042
Common Stock Repurchased 0-0.259-0.059000
Dividends Paid 000000
Other Financing Activities 1.050.2390.49-2.47362.2430.042
Financing Cash Flow 4.3278.1270.49102.52655.00921.37
Other Information:
Effect Of Forex Changes On Cash 000000
Net Change In Cash -4.62811.453-12.582-7.44722.633-0.038
Cash At End Of Period 13.55218.186.72719.30926.7564.123